TRATECIN Trademark

Trademark Overview

On Friday, August 1, 2008, a trademark application was filed for TRATECIN with the United States Patent and Trademark Office. The USPTO has given the TRATECIN trademark a serial number of 79060568. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, August 1, 2018. This trademark is owned by DAIICHI SANKYO COOMPANY, LIMITED. The TRATECIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, metabolic disorders, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation and inflammatory disease, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease; pharmaceutical preparations for contrast agent
tratecin

General Information

Serial Number79060568
Word MarkTRATECIN
Filing DateFriday, August 1, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, August 1, 2018
Registration Number3705516
Registration DateTuesday, November 3, 2009
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 17, 2009

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the word "TRATECIN" shown in all CAPS.
Goods and ServicesPharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, metabolic disorders, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation and inflammatory disease, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease; pharmaceutical preparations for contrast agent

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 10, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 103-8426
JP
Party NameDAIICHI SANKYO COOMPANY, LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Friday, March 1, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, March 1, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, May 5, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, February 18, 2017GENERIC MADRID TRANSACTION SENT TO IB
Saturday, February 18, 2017GENERIC MADRID TRANSACTION CREATED
Friday, February 10, 2017TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, June 10, 2016CANCELLED SECTION 71
Friday, March 25, 2016CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, December 10, 2015CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, November 7, 2015NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 26, 2010FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, March 3, 2010FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 3, 2010FINAL DISPOSITION PROCESSED
Wednesday, February 3, 2010FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 3, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, September 29, 2009EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, September 24, 2009CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Friday, September 11, 2009CORRECTION TRANSACTION RECEIVED FROM IB
Wednesday, April 15, 2009EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 17, 2009PUBLISHED FOR OPPOSITION
Wednesday, February 25, 2009NOTICE OF PUBLICATION
Friday, February 6, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, February 5, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 29, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 29, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 29, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 26, 2009ASSIGNED TO LIE
Thursday, January 22, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 22, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 26, 2008REFUSAL PROCESSED BY IB
Monday, November 24, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, November 24, 2008REFUSAL PROCESSED BY MPU
Friday, November 21, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, November 21, 2008APPLICATION FILING RECEIPT MAILED
Thursday, November 20, 2008NON-FINAL ACTION WRITTEN
Monday, November 17, 2008ASSIGNED TO EXAMINER
Monday, November 17, 2008NEW APPLICATION ENTERED IN TRAM
Friday, November 14, 2008LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Thursday, November 13, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

tratecin disease disorders infection pharmaceutical preparations inflammation inflammatory allergy viral bacterial